ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

A Machine Learning Model for Predicting Antibody Response to 2-Dose Sars-cov-2 MRNA Vaccine Series in Transplant Recipients

J. L. Alejo1, J. Mitchell1, T. Chiang1, A. Abedon1, W. Werbel1, R. Avery1, A. Tobian1, A. Massie1, J. Garonzik-Wang2, D. Segev1, S. Bae1

1JHU, Baltimore, MD, 2U of Wisconsin, Madison, WI

Meeting: 2022 American Transplant Congress

Abstract number: 537

Keywords: Antibodies, COVID-19, Vaccination

Topic: Clinical Science » Organ Inclusive » 72 - Machine Learning, Artificial Intelligence and Social Media in Transplantation

Session Information

Session Name: Machine Learning, Artificial Intelligence and Social Media in Transplantation

Session Type: Rapid Fire Oral Abstract

Date: Tuesday, June 7, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:50pm-6:00pm

Location: Hynes Room 210

*Purpose: Understanding risk factors for impaired vaccine responses can guide strategies for testing, additional dose recommendations, and vaccine schedules to provide improved protection in solid organ transplant recipients (SOTRs). Our purpose was to use machine learning to characterize risk factors and create a prediction model for seroconversion after 2-dose mRNA SARS-CoV-2 vaccination.

*Methods: Using our national observational cohort of 1031 SOTRs we created a machine learning model using gradient boosting to explore, rank, and quantify the association of 19 clinical factors with antibody responses to 2-dose mRNA vaccination. Gradient boosting is a general-purpose machine learning algorithm that generates a sequence of parsimonious prediction models based on the residual error of the previous models. We measured the area under the receiver operating characteristic curve (AUROC) via a 10-fold cross validation to evaluate the model’s performance. Finally, we evaluated the prediction performance of the models in discrimination and calibration with an external cohort of 512 SOTRs from Houston Methodist.

*Results: Mycophenolate mofetil (MMF) use, shorter time since transplant, and older age were the strongest predictors of seronegativity, collectively contributing to 76% of the model’s prediction performance (Figure 1). Other clinical factors, including organ type, vaccine type, sex, race, and other immunosuppression medications, showed weaker associations with seronegativity. Longer time since transplant was associated with higher odds of seropositivity, especially during the first 5 years post-transplant (Figure 2a). Older age among those <65 years old (Figure 2b) and MMF (Figure 2c) were associated with lower odds of seropositivity. The model had moderate prediction performance, with an AUROC of 0.79 (our cohort) and 0.67 (Houston Methodist cohort).

*Conclusions: Our machine learning model allows us to identify SOTRs at highest risk of suboptimal immunogenic response to vaccination, highlighting opportunities for improving protection from COVID-19 including more targeted vaccination strategies.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Alejo JL, Mitchell J, Chiang T, Abedon A, Werbel W, Avery R, Tobian A, Massie A, Garonzik-Wang J, Segev D, Bae S. A Machine Learning Model for Predicting Antibody Response to 2-Dose Sars-cov-2 MRNA Vaccine Series in Transplant Recipients [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/a-machine-learning-model-for-predicting-antibody-response-to-2-dose-sars-cov-2-mrna-vaccine-series-in-transplant-recipients/. Accessed May 26, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences